Pharmaceutical Pricing, Reimbursement and Market Access

 
 

Pharmaceutical Pricing, Reimbursement and Market Access examines a broad range of issues affecting the pharmaceutical industry, including prescribing trends, company pricing strategies, payers’ reimbursement policies, the growing use of pharmacoeconomics and health technology assessment and important changes in national health care systems. These reports provide timely insights into the challenges that the pharmaceutical industry faces in a volatile pricing and reimbursement environment.
 



Search Reports


Decision Resources Group brands include: